Alpha 2.0
Login Register
» Articles » PMID: 8869445

A Combination with Clinical Recommended Dosages of Salmeterol and Ipratropium is Not More Effective Than Salmeterol Alone in Patients with Chronic Obstructive Pulmonary Disease

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 1996 Sep 1
PMID 8869445
Citations 9
Authors
M G Matera
M Caputi
M Cazzola
Affiliations
Soon will be listed here.
Citing Articles

The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Tanimura K, Sato S, Fujita Y, Yamamoto Y, Hajiro T, Horita N Chron Respir Dis. 2023; 20:14799731231166008.

PMID: 36967224 PMC: 10052583. DOI: 10.1177/14799731231166008.

Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?.

Reddy C, Kanner R Drugs Aging. 2007; 24(8):615-28.

PMID: 17702532 DOI: 10.2165/00002512-200724080-00001.

Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Appleton S, Jones T, Poole P, Pilotto L, Adams R, Lasserson T Cochrane Database Syst Rev. 2006; (3):CD006101.

PMID: 16856113 PMC: 7200053. DOI: 10.1002/14651858.CD006101.

Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.

Appleton S, Poole P, Smith B, Veale A, Lasserson T, Chan M Cochrane Database Syst Rev. 2006; 3):CD001104.

PMID: 16855959 PMC: 11751769. DOI: 10.1002/14651858.CD001104.pub2.

Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Appleton S, Jones T, Poole P, Pilotto L, Adams R, Lasserson T Cochrane Database Syst Rev. 2006; (2):CD001387.

PMID: 16625543 PMC: 6513456. DOI: 10.1002/14651858.CD001387.pub2.